Medifast (NYSEMED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in two new science-backed nutrition plans designed for people on GLP-1 medications and those looking for help to keep weight off. The mini meals provide essential nutrients to promote muscle health, digestive health and bone health, and combined with the new plans and OPTAVIA’s holistic offer, fill a critical gap in the weight management market.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independent survey. Commissioned by Medifast and conducted by the third-party market research firm Talker Research, the goal of the survey was to better understand American perceptions of weight loss medications and their role in health journeys, while also identifying areas where further support is necessary.

What a brutal six months it’s been for Medifast. The stock has dropped 20.6% and now trades at $19.84, rattling many shareholders. This may have investors wondering how to approach the situation.

Let’s dig into the relative performance of Nu Skin (NYSENUS) and its peers as we unravel the now-completed Q3 personal care earnings season.

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including Olaplex (NASDAQOLPX) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with Medifast (NYSEMED).

Wellness products company Nature’s Sunshine Products (NASDAQNATR) will be reporting earnings tomorrow after market hours. Here’s what investors should know.

Personal care company Nu Skin (NYSENUS) will be reporting earnings tomorrow after the bell. Here’s what to expect.

Personal care company Edgewell Personal Care (NYSEEPC) will be announcing earnings results tomorrow before the bell. Here’s what to expect.

Hair care company Olaplex (NASDAQOLPX) will be announcing earnings results tomorrow before the bell. Here’s what to look for.

Wellness company Medifast (NYSEMED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell 40.6% year on year to $140.2 million. On the other hand, next quarter’s revenue guidance of $110 million was less impressive, coming in 16.4% below analysts’ estimates. Its GAAP profit of $0.10 per share was also 153% above analysts’ consensus estimates.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ended September 30, 2024.

Wellness company Medifast (NYSEMED) will be reporting results tomorrow after market hours. Here’s what investors should know.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

MED stock results show that Medifast beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Medifast (NYSEMED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024.

Discover three stocks to sell now. Even with bullish market conditions, read on to learn why these companies are doomed.

Medifast (NYSEMED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2024 on Monday, August 5, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

If the long-awaited sector rotation is happening, it’s time to look at these undervalued consumer staples stocks.

Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.

Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.

Medifast (NYSEMED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced that it has been recognized in the 2024-2025 rankings by U.S. News & World Report as one of the nation’s “Best Companies to Work For” in the food and drink industry. This recognition marks Medifast’s second straight year of inclusion on the list and underscores the company’s ongoing commitment to creating an outstanding workplace culture and enhancing the lives of its employees and customers.

GLP-1s are a weight-loss breakthrough, but these three stocks to sell have a lot to lose from their rapid rise in popularity.

These small-cap value stocks remain an overlooked market segment despite their inherent strength and outperformance likelihood.